Alembic Pharmaceuticals LimitedNSE: APLLTD

Alembic Pharmaceuticals Limited Press Release Jun 11 2026

· Issued by Alembic Pharmaceuticals Limited via NSE India

Filed with NSE · · 2 pages · English

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 11, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases